The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Harrow Stock Analysis - reflects ongoing discussions around financial markets, investor activity, and sector performance.

Harrow Inc (NASDAQ:HROW) and Taiwan-based Formosa Pharmaceuticals announced a licensing agreement on Monday. Harrow acquired the exclusive U.S. commercial rights for BYQLOVI (clobetasol propionate ...

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Harrow Health ( (HROW)) just unveiled an announcement. Harrow, Inc. has prepared a new ...

Investors considering a purchase of Harrow Inc (Symbol: HROW) shares, but tentative about paying the going market price of $32.54/share, might benefit from considering selling puts among the ...

Ratings for Harrow HROW were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the commercial launch of BYOOVIZ® ...

Is HROW a good stock to buy? We came across a bullish thesis on Harrow, Inc. on TopSecretStocks’s Substack by Simon. In this ...

Harrow Inc (NASDAQ:HROW) reported a 45% increase in total revenue for the third quarter compared to the same period in 2024, reaching $71.6 million. The company is on track for a strong year of ...